Clinical trial
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain…
NCT00033254 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00033254 |
|---|---|
| Title | Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases |
| Official title | A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (NSC#66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tumors Metastatic to Brain |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | radiation therapy, thalidomide, quality-of-life assessment |
| Enrollment | 332 |
| Start date | Mar 1, 2002 |
| Primary completion | May 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: